Human Immunoglobulin G Recognizing Fibrinogen-Binding Surface Proteins Is Protective against both Staphylococcus aureus and Staphylococcus epidermidis Infections In Vivo
Open Access
- 1 February 2006
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 50 (2), 511-518
- https://doi.org/10.1128/aac.50.2.511-518.2006
Abstract
A human donor-selected immunoglobulin G for intravenous injection (IGIV) product with elevated titers against the staphylococcal fibrinogen-binding MSCRAMM proteins ClfA and SdrG (INH-A21) was tested in vitro and in vivo. INH-A21 contained a significantly increased ability to inhibit the fibrinogen-binding activity of recombinant forms of both ClfA and SdrG. Evaluation of the opsonizing potential of INH-A21 was evaluated using fluorescently labeled bacteria; this assay indicated an increase in phagocytic activity compared to normal IGIV. The prophylactic efficacy of INH-A21 against an intraperitoneal challenge of methicillin-resistant Staphylococcus epidermidis (MRSE) was evaluated in a neonatal rat model. INH-A21 was also evaluated for prophylactic and therapeutic efficacy in a rabbit model of catheter-induced aortic valve infective endocarditis caused by either MRSE or methicillin-resistant Staphylococcus aureus (MRSA). Results from the in vivo models demonstrated potent prophylactic and therapeutic efficacy against both MRSE and MRSA. These data suggest that INH-A21 may be an important tool for the prevention and treatment of staphylococcal infections, especially in high-risk populations.Keywords
This publication has 30 references indexed in Scilit:
- Comparison of Antibody Repertoires against Staphylococcus aureus in Healthy Individuals and in Acutely Infected PatientsClinical and Vaccine Immunology, 2005
- Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance StudyClinical Infectious Diseases, 2004
- The Fibrinogen Binding Protein of Staphylococcus epidermidis Is a Target for Opsonic AntibodiesInfection and Immunity, 2004
- Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-ResistantStaphylococcus aureusBacteremia in an Experimental Model of Infective EndocarditisAntimicrobial Agents and Chemotherapy, 2003
- Involvement of Adherence and Adhesion Staphylococcus epidermidis Genes in Pacemaker Lead-Associated InfectionsJournal of Clinical Microbiology, 2003
- SdrG, a Fibrinogen-binding Bacterial Adhesin of the Microbial Surface Components Recognizing Adhesive Matrix Molecules Subfamily from Staphylococcus epidermidis, Targets the Thrombin Cleavage Site in the Bβ ChainPublished by Elsevier BV ,2001
- Clumping Factor A Mediates Binding of Staphylococcus aureus to Human PlateletsInfection and Immunity, 2001
- Identification of the ligand‐binding domain of the surface‐located fibrinogen receptor (clumping factor) of Staphylococcus aureusMolecular Microbiology, 1995
- Microbial adhesins recognizing extracellular matrix macromoleculesCurrent Opinion in Cell Biology, 1994
- Role of Intravenous Immunoglobulin in Prevention of Late-Onset Infection in Low-Birth-Weight NeonatesClinical Infectious Diseases, 1990